NCT06676254 Role of HbA1c in Predicting Adverse Pregnancy Outcomes
| NCT ID | NCT06676254 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National University of Malaysia |
| Condition | Gestational Diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 195 participants |
| Start Date | 2024-06-27 |
| Primary Completion | 2026-06-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 195 participants in total. It began in 2024-06-27 with a primary completion date of 2026-06-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to determine the reference value of HbA1c that can be used to predict adverse pregnancy outcomes. These adverse outcomes include LGA fetus, shoulder dystocia, caesarean section, pre-term birth, pre-eclampsia and fetal neonatal hypoglycaemia.
Eligibility Criteria
Inclusion Criteria: * Pregnant woman with singleton pregnancy * Confirmed diagnosis of GDM based on Malaysia CPG (≥5.1/7.8) * HbA1c level taken at least once at any time during the pregnancy * Delivery after 28 weeks gestation Exclusion Criteria: * Major fetal anomaly * Haemoglobin level of ≤9 g/dL (moderate or severe anaemia in pregnancy) * Women with autoimmune diseases * Overt diabetes or pre-existing diabetes
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06676254 clinical trial?
This trial is open to female participants only, studying Gestational Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06676254 currently recruiting?
Yes, NCT06676254 is actively recruiting participants. Contact the research team at drrahana@ukm.edu.my for enrollment information.
Where is the NCT06676254 trial being conducted?
This trial is being conducted at Cheras, Malaysia.
Who is sponsoring the NCT06676254 clinical trial?
NCT06676254 is sponsored by National University of Malaysia. The trial plans to enroll 195 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.